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Amongst the most important conditions in the differential diagnosis of epilepsy is the one that manifests as
paroxysms of altered behaviour, awareness, sensation or sense of bodily control in ways that often resemble
epileptic seizures, but without the abnormal excessive or synchronous electrical activity in the brain that defines
these. Despite this importance, there remains little agreement – and frequent debate – on what to call this
condition, known inter alia as psychogenic non-epileptic seizures (PNES), dissociative seizures (DS), functional
seizures (FS), non-epileptic attack disorder (NEAD), pseudoseizures, conversion disorder with seizures, and by
many other labels besides. This choice of terminology is not merely academic – it affects patients’ response to and
understanding of their diagnosis, and their ability to navigate health care systems.This paper summarises two
recent discussions hosted by the American Epilepsy Society and Functional Neurological Disorders Society on the
naming of this condition. These discussions are conceptualised as the initial step of an exploration of whether it
might be possible to build consensus for a new diagnostic label.
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Box 1
Seminar participants and flipped classroom contributors
FNDS (Functional Neurological Disorder Society)
Coordinator: Barbara A Dworetzky
Presenter: Benjamin Tolchin
Moderator: David L Perez
Discussion participants: Bridget Mildon, W. Curt LaFrance, Jr, Gaston Baslet, Laura Goldstein, Jon Stone, Maria Oto, Julia Doss, Nicole Roberts,
Jeffrey Buchhalter, Barbara A Dworetzky
AES (American Epilepsy Society)
Organisers: Julia Doss, Barbara A Dworetzky, Jerzy P Szaflarski
Presenters: Benjamin Tolchin, Julia Doss, Barbara A Dworetzky, Gregory L Barkley, Ellen Riker, Markus Reuber
Discussion participants: Julia Doss, Barbara A Dworetzky, Benjamin Tolchin, Gaston Baslet, W Curt LaFrance, Jr, Markus Reuber
Flipped Classroom material providers
FND Hope, Markus Reuber, Mark Hallett, Kasia Kozlowska, Aileen McGonigal

names, with subsequent moderated discussion seeking to elucidate what
we should want the name for the condition(s) to do. These discussions
were conceptualised as the initial step of an exploration, whether it
might be possible to build consensus for a new diagnostic label. Here we
summarise the key themes emerging from those discussions.

1. Introduction
It has caused me the greatest trouble, and for ever causes me the greatest
trouble, to perceive that unspeakably more depends upon what things are
called, than on what they are.” – [1]
When Nietzsche was troubled by the greater attention paid to names
than to the things themselves, he was probably not thinking about the
nosology of nonepileptic paroxysms associated with alterations of motor
and sensory function, perception, and awareness. However, it is
certainly the case that the naming of what has mostly been called psy
chogenic non-epileptic seizures (PNES) in the recent scientific litera
ture,1 but what has also been labelled as dissociative seizures (DS),
functional seizures (FS), non-epileptic attack disorder (NEAD), pseudo
seizures, and conversion disorder with seizures (to name only the most
frequently used labels) has caused vigorous debate. For instance, 10
years ago, the American Epilepsy Society (AES) hosted a discussion of
the favoured terminology, with lines being drawn in the pages of
Neurology. [2–4] A recent review by Ali Asadi-Pooya and colleagues [5]
opened the discussion again, provoking a range of responses. [6–8]
These discussions focus on words – and the words preferred in
different cultures, specialties, and fields of practice. But there is more to
a name than the words alone; in a 1962 book (to which the title of this
piece is owed), the British philosopher J. L. Austin draws attention to the
different things we do with words: warning, urging, threatening – or
naming. [9] He also draws a distinction between those things we try to
do with words, and the things we in fact achieve: the warned person is
appropriately cautioned, the urged persuaded, the threatened cowed.
What of the named – or diagnosed?
Two recent seminars hosted by the Functional Neurological Disorder
Society (FNDS) and the American Epilepsy Society (AES) held at the
start of December 2020 sought to address this question – not to debate
what to call PNES (the term currently recommended by the International
League Against Epilepsy [ILAE]), but to discuss what we are doing – and
what we should be aiming to do – when we give certain labels to the
condition(s) known inter alia as PNES. An international panel including
representatives of the epileptology, neurology, psychology, psychiatry,
paediatrics, and patient communities presented their contrasting views
of the intended functions and unintended consequences of different

2. Methods
2.1. Data
2.1.1. Seminars
Two 90-minute online seminars were held on the 3rd and 7th
December 2020, the first hosted by the FNDS as part of its weekly
Zoom® webinar series, the second by the PNES Special Interest Group
(SIG) of the AES as part of its 2020 Annual Meeting. The FNDS session
was an open-access event, whereas the PNES SIG could only be joined by
individuals who had paid to participate in the Annual AES Meeting. The
planning committee (under the direction of Barbara Dworetzky,
comprising members of AES PNES SIG and FNDS leadership) sought an
expert panel aiming to represent each of the following groups of interest:
patient advocate; paediatric psychologist; paediatric (child/adolescent)
psychiatrist; adult neuropsychiatrist; adult neuropsychologist; epi
leptologist specialising in FND; and epileptologist not specialising in
FND. The panel selection process intentionally sought to ensure a di
versity of gender, nationality, and background in the panel. The events
were advertised through relevant professional membership organisa
tions (FNDS, AES, ILAE, American Clinical Neurophysiology Society,
American Academy of Neurology (AAN), American Psychological As
sociation, American Neuropsychiatric Association, National Association
of Epilepsy Centers), patient groups (FND Hope) and on social media
(Twitter).
Each event took the form of a series of brief presentations from an
expert panel (see Box 1 for panellists in each seminar), followed by a
moderated discussion. Participants were able to leave comments and
post questions in a ‘chat’ box in writing. Questions were read out and
directed at particular experts by the meeting moderators, Dr David Perez
(FNDS) and Dr Julia Doss (AES SIG). Spoken and written (chat) content
from the sessions is included in this report.
2.1.2. Flipped classroom materials
We used a ‘flipped classroom’ model, whereby participants are invited
to view informational content online prior to the seminar, to provide a
shared knowledge base with which to enter the discussion. A series of

1
Use of the term PNES in this article reflects this convention only, and should
not be inferred to reflect that this is necessarily the preferred label moving
forward.
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recorded brief presentations offering different perspectives on the naming
of PNES were shared with participants prior to the events (see Box 1 for
contributors). These were intended to target known issues of contention
in the naming of PNES. Flipped classroom materials are available at
https://www.fndsociety.org/fnd-education/dec3-webinar-material.

could broadly be categorised into four concerning the intentions of
naming – what we might seek to do – and four concerning the conse
quences – what in fact occurs (see Box 2 for themes and codes within
each theme).

2.1.3. Survey
Following the seminars, participants were invited to complete two
brief surveys: one covering their opinion on the most important issues in
the naming of PNES, another inviting open responses to the flipped
classroom materials. Sixty-five respondents completed the first survey,
but only nine the second. Given very low response rate to the second, we
excluded responses from further analysis. References to ‘the survey’
below therefore refer to the first of these.

3.1. Intentions
3.1.1. Mechanism
A key focus of debate throughout the texts concerned the relation
ship between a name for PNES and its mechanism – the causal process
(es) by which the clinical phenomena variously labelled as PNES are
hypothesised to occur. Comments on mechanism addressed: whether
PNES is explained by a single mechanism or multiple mechanisms; the
level of explanation at which such mechanisms are situated; and the
value (or otherwise) of making reference to the underlying mechanism
in the name for PNES.
Despite extensive discussions of the merits and disadvantages of
names that make greater or lesser reference to mechanism (for instance
terms such as ‘psychogenic’ or ‘dissociative’), more participants felt that
other concerns were ultimately of greater terminological importance. In
the survey, the three aspects of a name most bound up with mechanism
(“connecting the disorder to a broader theoretical category or frame
work”, “identifying a putative aetiology of the disorder”, or “maintain
ing agnosticism for mechanisms/etiologies of disorder that remains
poorly understood”) were ranked as being the least important (see
Fig. 1).

2.2. Analysis
We used the seminars, flipped classroom material, and survey as data
for a thematic analysis conducted within a reflexive and contextualist
framework. [10] This involves familiarisation with the data before
generating codes that summarise and interpret ideas expressed. Coding
supports identification of themes from the data, which are then refined by
returning to the data. Our framework acknowledges the influence that
theoretical constructs drawn from prior discussions on the naming of
PNES are likely to have on our analysis, while allowing for their inductive
modification by codes emerging from our interpretations of the data.
3. Results

3.1.1.1. One mechanism or multiple. Considering whether a name for
PNES should describe its mechanism invites the question of whether
PNES even refers to a sufficiently distinct phenomenon amenable to
mechanistic explanation. Contributors to the seminars questioned this in
both directions. Reflecting discussions in previous publications, [11, 12]
participants asked whether PNES are a particular presentation of a
broader disorder (the ‘seizure variant’ of FND or conversion disorder).
Mark Hallett, a neurologist and neurophysiologist, made a case for this
in his contribution to the flipped classroom materials, highlighting that
PNES share overlapping epidemiology, clinical features, putative aeti
ology and pathophysiology, and treatment approaches with other forms
of FND. Or, as one participating neurologist asked in the chat, might it be
“mechanistically heterogeneous”, encompassing a syndrome resulting
from a range of different processes – in which case, might multiple names
in fact be more appropriate?2
Contributors to the FNDS seminar highlighted the context-sensitivity
of the degree of specificity required from a name. Resonating with
previously published conceptualisations of functional neurological dis
order, [13] Nicole Roberts, an experimental clinical psychologist,
demonstrated the relevance to PNES of a range of different constructs
(emotion processing, agency, attention, interoception, and predictive
inference) and underlying neural circuits (e.g. governing salience,
multimodal integration, and attention), proposing that these allowed for
both ‘cross-cutting’ and ‘sub-typing’ of explanations of PNES. Markus
Reuber, an epileptologist, proposed that this may permit a ‘staggered
approach’ to nomenclature for clinicians, with more or less specific or
mechanism-agnostic terminology being appropriate in different contexts
(for instance starting with a term such as “functional seizure” when an
episode has been found not to be caused by epileptic activity, and
specifying this to “dissociative functional seizure” when a more specific
psychological mechanism has been identified).

We identified eight salient themes within the different materials
summarised (seminars, flipped classroom materials, and survey). These

Box 2
Themes and sub-themes
Intentions
• Mechanism
One mechanism or multiple
The ‘psychogenic’ question
Mechanistic vs. mechanism-agnostic naming
• Therapeutic benefit
Names as treatment
Defining ‘benefit’
• Communication
From specialists
From patients
Between languages
Institutional and administrative functions
Consequences
• Stigma
Acceptability of names
Names to address stigma

3.1.1.2. Should a label reference ’psychogenicity’?. As introduced by
Aileen McGonigal, an epileptologist, in her pre-seminar video, the

Stigmatisation from the health community
• Dissonance and disagreement
• Barriers to care

2
We thank an anonymous reviewer for highlighting the need to emphasise
this point.

• Labels shape people
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Fig. 1. Respondents’ ranking of relative importance of different considerations in determining a name for the disorder (6-point Likert scale from most to least
important; bars represent proportion ranking a consideration of given importance, where darker colours are more important, lighter less).

alterations of function culminating in PNES can be understood as
occurring at the level of neurophysiology, [14–16] but at present psy
chological models are relatively more developed. [17, 18] While most
participants in both seminars eschewed the mind-body dualism that has
held these different levels of explanation to be fundamentally different
in kind, a number of arguments were made emphasising one or the
other. Gaston Baslet, a neuropsychiatrist, as well as several audience
members, argued for a name that at least retains a “conceptual link” with
the term ‘psychogenic’, with the hope that understanding the condition
in such terms will support engagement with the present best-evidenced
(psychological) treatments. W. Curt LaFrance Jr (a neurologist and
psychiatrist) favoured use of ‘conversion’ on such grounds. In his
treatment experience in clinic and extensive research on patient out
comes, making this psychological mechanism explicit supports patients
in finding alternative means of managing challenging emotions – and
thus breaking the link to their symptomatic episodes. Laura Goldstein,
an adult clinical neuropsychologist, gave support for ‘dissociation’ by
noting that “it’s a term that conveys a mechanism to work with”; based
on her group’s research and related clinical activities she finds that
patients can draw from everyday understandings of more familiar
dissociative phenomena, to come to understand how similar processes
might produce their own experiences.
By contrast, Rebecca Geiger – a person with a diagnosis of FND –
suggested that emphasising a psychological aetiology may cause
confusion for patients whose own phenomenal experience is over
whelmingly physical, and who may find their events accompanied by an
array of other physical symptoms. A putative solution to this impasse
was provided by those who advocated an explicitly biopsychosocial
approach to naming the condition. Reflecting suggestions made else
where, [19] McGonigal highlighted successes in multi-scale modelling
of other neurological disorders – where mechanisms operating at
different levels of explanation are employed in complementary, rather
than competing, fashion. Roberts proposed the use of a name that
explicitly describes the mechanisms operating at psychological and
neural circuit levels (e.g. “emotion dysregulation and emotional inter
oception disorder”).

3.1.1.3. Mechanism-specific vs mechanism-agnostic naming. While the
arguments in the previous section highlighted the advantages of refer
ring to a particular mechanism in the name of the condition, other
participants stated that uncertainty over underlying mechanisms was a
reason to favour an agnostic approach. Jon Stone, a neurologist,
observed that many other conditions (e.g. migraine, multiple sclerosis)
do not wear their (complex) aetiologies on their sleeves. Using migraine
as an example, he suggested that names not making explicit reference to
psychological causation may support rather than inhibit engagement
with psychological factors (such as stress) contributing to the condition.
Bridget Mildon, representing the patient organisation FND Hope, pro
posed that patients’ preference for the term ‘functional seizures’ may in
part stem from its lack of commitment to an underlying mechanism; this
“allowed researchers and clinicians to keep an open mind” in
approaching the condition. This would contrast to the inference (false,
as highlighted by LaFrance) made by some clinicians that patients with
PNES all have a history of trauma or abuse; while reported adverse life
events are highly prevalent amongst those with PNES, they are not
universal. [20] Barbara Dworetzky, a neurologist, also drew attention to
the need to avoid premature closure in our hunt for the mechanisms of
the disorder. She noted that (as discussed by McGonigal in her
pre-seminar material), modelling at various levels (including structural
anatomy, neurological networks, and psychological processes)
contribute to our understanding of the condition. Opting for a name that
emphasises the (presently most-developed) psychological mechanisms
risks dismissing the importance of others; or, perhaps of more immediate
clinical relevance, “licensing people [who do not treat ‘psychological’
problems] to say ‘I don’t need to know this.’” Open-ended terms like
‘functional’ can be understood as operating across these levels – i.e. in
explicitly biopsychosocial fashion – since function and dysfunction are
relevant concepts at all levels.
However, open-endedness runs the risk of moving toward mean
inglessness. As highlighted in an animated dramatization of the expe
rience of a person with PNES navigating their first hospital assessment
(shared with seminar attendees by Dworetzky, courtesy of Bernd Pohl
mann, an epileptologist), contentless names (NEAD arguably being the
105
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commonly used term coming closest to this) can allow clinicians to
absolve themselves of responsibility for dealing with a real problem, and
leave patients in a state of uncertainty, told only that “you have
nothing”.
Even when names are not completely empty, open-endedness may
fail to capture clinically relevant distinctions. McGonigal highlighted
that current use of the term ‘functional’ may cause some confusion since
disturbances of brain ‘function’ (as recorded e.g. with EEG) are the
hallmarks of other conditions (such as epilepsy) to which functional
diagnoses are otherwise contrasted. At worst, the use of ‘functional’/
’structural’ dichotomy may simply replicate ‘mind’/’body’ dualism by
another name (see box 3).

one amongst US neurologists at least, following his recent informal
survey of AAN members responding to discussion of a draft guideline.
Reuber observed that this confusion may not just arise in communica
tion with patients or families, but also other professionals. Non-expert
clinicians, especially those needing to make time-sensitive decisions in
high-pressure environments on the basis of limited information, hearing
‘seizure’ may be inclined to treat as epilepsy – with potentially
dangerous, even fatal, consequences for people with PNES. [24] How
ever, despite its drawbacks the term ‘seizure’ came out as preferred by
most respondents to the post-seminar survey (Fig. 3).
3.1.3.7. Communication from patients. Mildon observed that communi
cation is also a concern for patients – “how do [patients] convey to other
people in the outside world what is wrong with them?” For this purpose,
she proposed that ‘seizure’ “very clearly explains what is happening”,
whereas more neutral terms like ‘event’ “leave the patient having to go
on further” in their explanation. In contrast, Reuber referred to his
previous research demonstrating that some people with PNES show
resistance to the ‘seizure’ label [25].

3.1.2. Therapeutic benefit
Discussion around the therapeutic role of naming concerned:
whether names could prove therapeutic by helping patients and families
to understand and engage with the diagnosis (and consequent treat
ment); and how ‘therapeutic benefit’ should be defined. The function of
“Minimizing stigma +helping patients/families to understand and
engage with the diagnosis” was ranked as the most important consid
eration when choosing a name in the survey.

3.1.3.8. Communication between languages. Discussions around naming
should account for its use in different languages and cultures, as well as
by and for different audiences. In some cases, terms will have different
connotations in different languages. For instance, as observed by
McGonigal, the term ‘dissociation’ has a strong historical association
with schizophrenia in Francophone psychiatry. In others, the semantic
nuances are lost altogether in translation. Christian Hoppe, a psychol
ogist, demonstrated the most extreme version of this when he noted that,
in German, the different words ‘seizure’, ‘fit’, and ‘attack’ are simply not
used in the medical context – all would be translated as the single term
“Anfall”.
Jeffrey Buchhalter, an epileptologist, suggested incorporation of
whatever terms are decided upon to be included in the Systematized
Nomenclature of Medicine – Clinical Terms (SNOMED CT). This is an
international clinical vocabulary/taxonomy that would allow research
across languages facilitated by a common coding system. SNOMED CT’s
structured “ontology of medical knowledge” could facilitate under
standing the relationships between symptoms and functional neuro
logical disorders.

3.1.2.4. Names as treatment. Some participants reported that, in their
experience, different choices of terminology can affect patient outcome
and thus names can play a therapeutic role. Reflecting the findings of
previous studies, [21] Kasia Kozlowska, a child and adolescent psychi
atrist, reported – and Julia Doss, a child psychologist, agreed – that,
within the context of child and adolescent care, choice of language could
play a therapeutic role by “activat[ing] positive hopes and expectations
and [steering] the child towards healthy thinking, healthy actions, and
healthy future outcomes.” For this reason, Kozlowska reported that she
avoids terms that children and adolescents interpret negatively – for
example, “psycho” meaning mad, “pseudo” meaning fake, or “behav
ioural” meaning naughty – because such terms activate anger and
distress, and are therefore countertherapeutic and illness-promoting.
3.1.2.5. Defining benefit. Reuber highlighted that this purported func
tion is more complex than it perhaps sometimes appears in debates
surrounding naming: not only do we lack solid evidence of whether
choice of name promotes better or worse outcomes; we have failed to
specify what a good outcome is. Existing research studies on the ‘number
needed to offend’ of particular choices of nomenclature [22, 23] do not
actually cover clinical outcomes: do particular names affect rates of
seizure freedom, engagement with treatment, or patient and family
acceptance? Such questions are amenable to empirical study, but the
evidence does not yet exist.

3.1.4. Institutional and administrative functions
Several participants drew attention to the institutional functions
played by names. A 2019 FND Hope patient survey reported that 65%
felt that their current diagnostic label had adversely affected their care.
Some labels may erect obstacles to receiving appropriate care, while – as
Dworetzky put it – if nothing else, “‘seizure’ gets you into the seizure
specialist’s office.” Of course, this is only of value to the extent that said
specialist acknowledges their role (and perhaps more importantly, those
of other disciplines) in the diagnosis and treatment of PNES.
Some terms (such as ‘conversion’ and ‘dissociation’) already exist
within standard diagnostic classifications such as the ICD and DSM.
Goldstein observed that this has practical utility, even if only in obeying
Ockham’s admonition to avoid the unnecessary multiplication of en
tities. However, this issue is complicated by the use of such classifica
tions for administrative as well as clinical functions. Gregory L Barkley,
an epileptologist, described how the intimate relationship between ICD
codes and payment for services in the US can erect barriers to care. Such
payments vary with patterns of healthcare consumption associated with
different groups of conditions, which has historically constrained the
kinds of terminology that could be used for PNES. While making refer
ence to the psychological components of PNES may be preferable for
other reasons, in billing terms, PNES does not behave like other condi
tions coded as ‘psychiatric’ – addressing it within the ‘seizure’ category
more accurately reflects how patients interact with healthcare services.
Other terms like ‘events’ or ‘spells’, meanwhile, have no place in ICD

3.1.3. Communication
The communicative function of names was addressed with respect to
different speakers and audiences: from specialist to patient; from patient
or specialist to other clinicians; and from patients to their friends,
families, and communities. The texts also addressed issues of commu
nicating between different languages.
3.1.3.6. Communication from specialists. Exchanges around the use of
the term ‘seizure’ and its alternatives (attack, event, episode) serve as
microcosm for the broader questions around communication raised by
choice of terminology. Maria Oto, a psychiatrist and epileptologist, drew
attention to the implications of this choice in her presentation, arguing
that the close semantic association between ‘seizure’ and ‘epilepsy’
could often cause confusion when the former was used to refer to
something other than epilepsy, this being amplified for the many people
with PNES who may either have been previously misdiagnosed with
epilepsy or else experience comorbid epileptic seizures. Benjamin Tol
chin, an epileptologist, highlighted that Oto’s concern was a common
106
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codes at all. Such coding is also used in retrospective research, and the
lack of consistent coding – and the possibility of the condition falling
between ‘neurological’ and ‘psychiatric’ codings – may contribute to
some of the research lacunae in PNES. The significance for research does
not only look backwards, however; classifications may shape future
research directions and funding opportunities, potentially emphasising
different aspects of the condition.

must be responsible, because the lay public does not know what tech
nical terms such as ‘functional’ mean in medical contexts, so “it’s
important that we look at how the medical community perpetuates this
bias.” She suggested a “hidden curriculum” (as described elsewhere)
[26] socialises health workers into this bias; the differing ‘prestige’
afforded to different conditions amongst health workers – and the sta
bility of these ratings across time – does suggest that negative attitudes
toward some conditions persist in the health community. [27] Others
also argued for a need for change in healthcare education to address this:
Baslet commented that PNES and other conditions need to be
acknowledged in medical training “as early as possible” to prevent this
process.

3.2. Consequences
3.2.1. Stigma
Stigma was one of the most prevalent themes in the data, and
considered highly important by participants. Survey participants ranked
“Minimizing stigma +helping patients/families to understand and
engage with the diagnosis” as the most important function of a name for
PNES. Discussions on the theme of stigma concerned: the potential of a
name to reduce or perpetuate stigma; the influence of stigma on the
acceptability of names for patients; and the role of the healthcare
community in perpetuating stigmatisation of PNES.

3.2.2. Dissonance and disagreement
One important emerging theme was that of dissonance within and
between different stakeholder groups as to the best choice of terminol
ogy and the most important factors in shaping that terminology. This
was evident in the survey, which displayed a wide spread of termino
logical preferences (see Figs. 2 and 3 ). Within this theme, there also
emerged reference to how this dissonance itself can be a cause of diffi
culty. The disagreement on name – and its implications of disagreement
regarding the nature of the condition itself – could cause confusion for
patients and families, impeding understanding and acceptance of the
diagnosis. As Mildon commented: “When the medical community can’t
even agree on a name and terminology, it really discredits the diagnosis
in general.” This does perhaps underestimate just how common an
occurrence the proliferation of names is throughout medicine, however
– multiple names for the same condition is perhaps the rule and not the
exception.

3.2.1.9. Stigma and acceptability. Acceptability of a label to those who
bear it ranked highly amongst many participants’ objectives. Several
referred to previous research on the perceived offensiveness of different
names for PNES. [22, 23] As argued by Stone, such offensiveness is
usually bound closely with associated stigma – “and stigma tends to
change and move with the term.” This point was used by several par
ticipants to argue that choosing a name was of secondary importance
until the processes driving the stigma attached to those labels were
addressed. However, as Dworetzky highlighted, utopian visions of a
future free of stigma do not help patients in the here and now; and until
we reach that future “patients need something to say” to their family,
friends, and colleagues – using a name that does not harm them and
helps them engage in treatment remains important.

3.2.3. Barriers to care
Related to, but distinct from, the administrative theme identified
above, another emerging theme was of the choice of name as a potential
barrier to care. The 2019 FND Hope patient survey suggested that nearly
two thirds of respondents experienced their diagnostic label as adversely
affecting their ability to access appropriate healthcare. [28]
This theme involved discussion of how different terminology may
influence referral pathways – for instance the term ‘seizures’ (but not
necessarily ‘events’ or ‘attacks’) facilitating the referral to a seizure
specialist. They may also influence available treatments. The repur
posing of clinical terminology for administrative purposes – e.g. by in
surance companies or other payers – may inhibit access. Mildon
suggested that: “It’s really difficult for patients with a psychological
definition and coding to access physical therapy when they need it, or
sometimes [occupational therapy] … It literally can change whether a
patient can access appropriate treatment.” This highlights the multimodal treatments that can affect this disorder and the need for the
name to not limit this access.
Of course, patients with PNES do not just present to neurologists with
epileptic-seizure-like events, they also present to specialists in internal
medicine or cardiologists with syncope-like (atonic/unresponsive)
events (sometimes called “pseudosyncope”), or to movement disorder
specialists with abnormal involuntary movements. As Reuber said, given
that both types of presentation are thought to be underpinned by the
same pathological process, an ideal label would need to work for the
latter type of presentation as well.

3.2.1.10. Names addressing stigma. Elsewhere, however, comments
addressed the potential of names as a tool to reduce stigma. Roberts, by
drawing an analogy with attention deficit hyperactivity disorder
(ADHD), raised hopes that a diagnostic label could “legitimise […] in a
biological way that may be helpful.” Other participants suggested that
specifically incorporating the physical or biological components of the
condition into the name would be important for this process, whereas
emphasising the psychosocial aspects “does a disservice to patients who
are trying to find treatments [for physical symptoms]” (Geiger, FNDS
webinar) – especially when, without a diagnosis, insurers will not cover
such treatment.
The distinction between biological and psychological and its relation
to stigma also manifested in comments addressing mind-body dualism in
medicine. Some suggested this dualism as a source of stigma, being
particularly attached to the ‘mind’ side. Lorna Myers, an adult psy
chologist, proposed that resisting this stigma requires a name and
practice that helps patients and families to understand “there is no
shame in having a psychological condition.” By contrast, avoidance of
terminology to make something more palatable in the short term may
exacerbate its stigmatisation. David Perez, a neurologist and psychia
trist, proposed that an understanding of PNES and FND more broadly as
biopsychosocial conditions could serve to mitigate this: “We know that
mental illness in society is stigmatised, and there is a divide between
physical health and mental health. I have oftentimes wondered if FND –
at the intersection […] is an avenue frankly to tackle that stigma, that
mental health and physical health are not (inherently) separate.”

3.2.4. Labels shape people
Several contributors expressed ideas reflecting the views of the
philosopher Ian Hacking, who observed that the engines of scientific dis
covery have an unusual effect when directed at human categories: rather
than presenting fixed targets, human experiences are modified by scientific
attempts to classify them. The very fact of being described in a certain way
can shape those classified, how they perceive themselves and their position
in the world. [29, 30] At several points participants addressed how the
classification of PNES might do more than just name – for some who

3.2.1.11. Stigmatisation by healthcare institutions. Several participants
discussed the tendency for stigmatising associations to be transferred
between terms. Some questioned the individuals and institutions driving
this process. Mildon proposed that healthcare workers and institutions
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Fig. 2. Preferred prefix.

Fig. 3. Preferred suffix.

internalise the name, it might create a particular way of being. In contrast,
patients who externalise their diagnosis have said, “I have seizures, but my
seizures don’t have me.” [31] While patients may approach their diagnosis
differently, the burden of illness remains: in Mildon’s words, patients “take
their diagnoses home […they] live with them every day.”
Roberts expressed a concern that “biology in a name can be con
straining”, suggesting that certain ways of naming the condition may
shape people’s self-perception in a way that impedes their recovery. She
cited the example of ‘mild traumatic brain injury’, a name from which
patients can infer permanent brain damage and thus an expectation of
permanent cognitive deficit. [32, 33] Reuber suggested that the ways in
which different labels make up people may differ in where they attribute
agency and the locus of control. He referenced recent research on the
different language used by people with diagnoses of “FND” compared
with “conversion disorder”, describing how those with the FND diagnosis
are more likely to describe their minds or selves as passive, in relation to a
body or brain that is ‘out of control’; those with a conversion diagnosis are

more likely to view the mind as active agent, and the self as a resilient
entity, able to find ways to reinstate control. [34]
There remains an open question whether any terminology for or
model of the disorder could capture all that is most relevant to those
experiencing it. Many people with the condition have lived through and
been unable to prevent experiences that are irreconcilable with their
core moral beliefs, morally injurious “soul wounds.” [35] The experi
ence can leave the person “sitting uncomfortably in [their] physical and
metaphysical chair.” [36] If nothing else, this serves as reminder that the
nosological map is not the territory of all human experience, [37] and
what is most relevant from the medical perspective may not./’ be what is
most important for the person labelled.
4. Discussion
The discussions arising in these two seminars were not intended to
provide a consensus on naming for PNES – indeed, they highlighted
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persisting dissonance over terminology. However, they showed a sig
nificant development from preceding debates in the inclusion of the
voices of those who experience the condition, and the weight placed by
participating clinicians on their perspective. However, in the absence of
broader consultation with other professional and patient groups and the
arguments put forward against these particular terms, the findings of the
survey should only be regarded as a preliminary step along the journey
of negotiating an optimal name for PNES.
There was general support for a unifying name – for the sake of the
patients who bear the label, and communication within and outside med
icine. This support was tempered by acknowledgement that potential
heterogeneity of mechanism or different therapeutic objectives may merit
use of different terminology in different contexts, or a nested approach
incorporating both broader and more specific names. Potential advantages
and disadvantages suggested for different names are summarised in Box 3.
A plurality of respondents to the post-seminar survey favoured the
terms ‘functional’ and ‘seizures’. This contrast with the results of recent
discussions amongst AAN members (who sought to move away from use
of these terms) perhaps reflects the involvement of participants living
with the condition, and the relative priorities of survey respondents:
while the arguments for avoiding the term ‘seizure’ chiefly concern
mechanism and communication between specialists, Mildon suggested
using it might help people with the condition communicate within their
communities while avoiding stigmatisation.
There was, however, a diversity of opinion regarding what we should
aim to be doing with a name. The themes explored above cover many of
these – contrasting, and even potentially conflicting – objectives. That
naming should support (or at least not impede) access to treatment and

successful outcomes was understandably a priority both for those
working with and those experiencing the condition. A name should also
function across contexts (clinical, social, and cultural or linguistic), and
minimise dissonance and disagreement regarding the nature or legiti
macy of the underlying condition.
There was also recognition that diagnostic labels do not exist purely
within the clinic; those with the condition carry their labels with them
throughout their lives. The potentially stigmatising consequences of
names were a recurrent concern throughout the seminars. Link and
Phelan’s influential model of the process of stigmatisation begins with
identification and labelling of difference [38] – thus names are indeed
closely bound up with stigmatisation. The means of preventing stig
matisation are less clear. New labels can quickly come to bear the same
associations. Several patients and some clinicians suggest that empha
sising the biological aspects of the condition would be a “legitimising”
manoeuvre in addressing stigma. The example of psychiatric conditions
such as schizophrenia, however, may prove cautionary here – in general
the promise of biological explanations has not reduced, and may even
have increased, negative associations attached to these conditions.
[39–41]
Having thus drawn some preliminary perspectives on what the
clinical community should be seeking to do with its words, there re
mains the question of how best to do it. The results of these seminars will
inform further work on this subject by the FNDS. Additionally, the ILAE
PNES Task Force is proposing a plan to create a consensus diagnostic
label for the condition currently termed PNES. A multi-stage, mixedmethod process involving an international, multi-lingual survey of
relevant patient and professional groups (ideally not only representing

Box 3
Candidate names for PNES.
Prefixes
PREFIX
Functional

POTENTIAL ADVANTAGES
• Unified terminology with conditions sharing
epidemiology, clinical features, putative aetiology
and pathophysiology, and treatment approaches
• Patient preference
• Mechanistically-agnostic within the
biopsychosocial model
• Understanding the condition in psychological terms
supports engagement with the present bestevidenced treatments

Psychogenic

Non-epileptic

• Mechanistically-agnostic

Specific mechanisms
(dissociative,
conversion)

• Provide a mechanism intelligible to lay
understanding that permits interpreting and
engaging with problem

Suffixes
SUFFIX
Seizures

POTENTIAL ADVANTAGES
• Clear explanation of phenomenology enables
patients to communicate with their community

Attacks

• Avoids conflation with epilepsy

Other (event, episode,
spell)

• Distinguishes from both epileptic seizures and
panic attacks

POTENTIAL DISADVANTAGES
• Lack of explanatory utility
• Confusion with other uses of ‘function’ in medicine

• Dissonance with patient experience being largely
physical
• May license disengagement from clinicians in
‘physical health’ specialties
• Putative barriers to accessing non-psychological
therapies
• Failure of explanation
• Absence of positive statement of problem may absolve
clinicians from responsibility for treating
• Posits specific mechanism that may not be applicable
in all cases

POTENTIAL DISADVANTAGES
• Lay association with epilepsy may lead to
misunderstanding by patients, relatives, and nonspecialists
• May require further explanation for patients to
explain to their community
• Unfamiliar medical terminology; leaves patients with
label having further explanatory work to
communicate diagnosis and providers to justify
healthcare resource utilization
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those with an interest in epileptology and psychiatry but also psycho
somatic medicine, psychotherapy and syncope) regarding the most
commonly used terminology and stakeholders’ perspectives on these
terms could be subjected to qualitative and quantitative analysis. The
results of this analysis could then inform a second-round survey on re
spondents’ conclusions regarding the acceptability of different terms.
Nietzsche notwithstanding, the question of what things are called
may not be more important than what they are. In the case of PNES,
these two questions may not be readily separable. Clinicians treat people
– with complex personal narratives, values, and systems of meaning –
not diagnoses; but diagnoses can facilitate or obstruct that process. For
those living with the condition, finding a common consensus name for
(what is currently called) PNES (or at least a commonly agreed, least
worst option) may be an important step in sharing with their community
and their clinicians what the condition is.
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